TAIFLEX Scientific Co., Ltd.

As of June 30, 2026, TAIFLEX Scientific Co., Ltd. carries a market capitalization of 39.29B, placing it among publicly traded companies globally. Its enterprise value stands at 36.79B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

TAIFLEX Scientific Co., Ltd.'s next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, TAIFLEX Scientific Co., Ltd. has 263.67M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, TAIFLEX Scientific Co., Ltd. maintains a current ratio of 2.38, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, TAIFLEX Scientific Co., Ltd. recorded 161.91M in income tax expense.

As of the close on October 22, 2026, TAIFLEX Scientific Co., Ltd.'s stock has gained approximately 306.11% over the past 52 weeks. The 50-day moving average sits at 285.96, while the 200-day moving average is 170.32.

As of June 30, 2026, TAIFLEX Scientific Co., Ltd. holds 3.94B in cash and equivalents against 1.42B in total debt, resulting in a net debt position of -2.97B. Total book value stands at 11.20B, with working capital of 6.06B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

TAIFLEX Scientific Co., Ltd.'s most recent stock split took place on July 23, 2024 with a 87:91 split ratio.